Via Scoop.it – ALS Lou Gehrig’s Disease
The Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) is actively seeking participants for a study designed to identify and validate biomarkers in amyotrophic lateral sclerosis (ALS). A biomarker is a biological indicator that can be used to measure the onset or progression of a disease, how a disease is reacting to a treatment or how a drug is behaving in the body. The purpose of the study is to collect biological samples from a number of people with ALS, and bank them for current and future usage in ALS research. Study investigators expect to enroll approximately 250 participants for the study, which is set to take place at six sites: Phoenix, Ariz.; Jacksonville, Fla.; Atlanta; Charlestown, Mass.; Worcester, Mass.; and Pittsburgh.
Via alsn.mda.org
24 Jan
ALS Research News 